Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy

Overview of attention for article published in Cellular and Molecular Life Sciences, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source
patent: 3 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 118 Mendeley

Summary Policy documents Patents Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Emerging Drugs for Duchenne Muscular Dystrophy

Cited by Canadian Agency for Drugs and Technologies in Health on 23 Jun 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.